Compare McKesson Corporation (MCK) vs SoundHound AI Inc (SOUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs SoundHound AI Inc — how do they compare? McKesson Corporation trades at $886.46 (market cap $105.14B), while SoundHound AI Inc trades at $7.35 (market cap $3.29B). The key difference: McKesson Corporation is far larger — about 32× SoundHound AI Inc's market cap, and McKesson Corporation pays a 0.42% dividend while SoundHound AI Inc pays none. Which is the better fit depends on your goals.
| MCK | SOUN | |
|---|---|---|
Market Cap | $105.14B | $3.29B |
Sector | Health | Technology |
52-Week High | $995.69 | $21.40 |
52-Week Low | $659.01 | $5.70 |
Enterprise Value | $111.67B | $3.09B |
Dividend Yield | 0.42% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson (MCK) trades at $889.01, up 1.04% today, with a bullish technical outlook and strong institutional support. Recent Q1 2027 earnings beat expectations, with EPS of $9.93 versus $9.56, driven by specialty drug growth and oncology performance. Revenue reached $359.05B in 2025, with net income of $3.30B, though margins remain thin. The company raised full-year guidance, reflecting operational momentum.
The stock offers upside to the consensus price target of $990.67, supported by 80% analyst buy ratings. Key risks include reliance on pharmaceutical distribution margins, regulatory pressures, and competitive threats. Earnings consistency and cost discipline are critical for sustaining valuation multiples amid healthcare sector volatility.
SOUN trades at $7.35, down 1.47% on the day, with a bullish technical signal from moving averages. The company reported strong revenue growth of 45% in Q2 2026 and raised its full-year outlook, driven by its OASYS platform. However, it remains unprofitable with a net income margin of -67.45% and negative cash flow from operations. Analyst sentiment is positive with a 75% buy rating and an $8.50 consensus price target.
The outlook hinges on SOUN's ability to convert rapid revenue growth into profitability. Investment opportunity lies in market leadership in voice AI and enterprise adoption via OASYS. Key risks include persistent cash burn, high valuation multiples, and execution challenges in integrating acquisitions like LivePerson.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About SoundHound AI Inc
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →
